Sun 1 Nov 2026 23:09:08 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

RTF Template


Bulgarian Drug Agency

UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

Human medicinal products


1. Authorisation Number

:

BG/WDA/MP-0594

2. Name of Authorisation Holder

:

Bulmar Ml OOD

(ORG-100021967 / LOC-100032400)

3. Address(es) of Site(s)

:

кв. Манастирски ливади, ул. Пирин № 32/, 32 Pirin Str., "Manastirski livadi" district, гр. София/ Sofia, 1618, Bulgaria 

2E Akad. Ivan Geshov Blvd., Busin. Center Serdica,build.6, kota 0,st.3, Sofia, region Vazrajdane, 1330, Bulgaria 




4. Legally registered address of Authorisation Holder

:

Kv Manastirski Livadi, Ulitsa Pirin 32, Sofia, 1618

5. Scope of authorisation

:

ANNEX 1

6. Legal basis of authorisation

:

Art. 77(1) of Directive 2001/83/EC

7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation

:

Confidential, Confidential

8. Signature

:


9. Date

:

2025-09-24

10. Annexes attached

:

Annex 1 Scope of wholesale distribution authorisation

Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

Annex 3 (Optional) Name(s) of responsible person(s)

Annex 4 (Optional) Date of Inspection on which authorisation was granted

Annex 5 (Optional) Additional provisions based on national requirements


ANNEX 1

SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



Name and address of the site: „БУЛМАР МЛ" ООД/ BULMAR ML OOD

, кв. Манастирски ливади, ул. Пирин № 32/, 32 Pirin Str., "Manastirski livadi" district, гр. София/ Sofia, 1618, Bulgaria   



Human medicinal products


1. MEDICINAL PRODUCTS

   1.1. with a Marketing Authorisation or registration in EEA country(s)

   1.2. without a Marketing Authorisation or registration in the EEA and intended for EEA market*

   1.3. without a Marketing Authorisation or registration in the EEA and intended for exportation


2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

   2.1. Procurement 

   2.2. Holding 

   2.3. Supply 

   2.4. Export 


3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

   3.1. Narcotic or psychotropic products** 

   3.2. Products requiring low temperature handling 

     3.2.1. Temperatures between 2 to 8 °C 

     3.2.2. Other temperatures: (please specify) 15°C - 25°C 15°C - 25°C

   3.3. Other products: (please specify here or make a reference to Annex 5) Medicinal products derived from blood and immunological medicinal products лекарствени продукти получени от кръв и имунологични лекарствени продукти




Name and address of the site: BULMAR ML OOD

, 2E Akad. Ivan Geshov Blvd., Busin. Center Serdica,build.6, kota 0,st.3, Sofia, region Vazrajdane, 1330, Bulgaria   



Human medicinal products


1. MEDICINAL PRODUCTS

   1.1. with a Marketing Authorisation or registration in EEA country(s)

   1.2. without a Marketing Authorisation or registration in the EEA and intended for EEA market*

   1.3. without a Marketing Authorisation or registration in the EEA and intended for exportation


2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

   2.1. Procurement 

   2.2. Holding 

   2.3. Supply 

   2.4. Export 


3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

   3.2. Products requiring low temperature handling 

     3.2.1. Temperatures between 2 to 8 °C 

     3.2.2. Other temperatures: (please specify) 15°C - 25°C 15°C - 25°C

   3.3. Other products: (please specify here or make a reference to Annex 5) Medicinal products derived from blood and immunological medicinal products лекарствени продукти получени от кръв и имунологични лекарстени продукти





*Art. 5 of Directive 2001/83/EC, Art. 83 of Regulation (EC) 726/2004 and Art. 110 of Regulation 2019/6.

**Without prejudice to further authorisations as may be required according to national legislation.













Union Format for a Wholesale Distribution Authorisation

BG/WDA/MP-0594


Page 1





Loading, please wait